In NB, attempts have been made to target MYCN‐MAX dimerization or inhibit MYCN‐MAX binding to DNA to block and arrest tumour development, and this has been a very long‐standing and relatively attractive perspective. The gene discussed is MYCN; the disease is neoplasm.